Literature DB >> 6294332

Identification and nucleotide sequences of two similar tandem direct repeats in Epstein-Barr virus DNA.

T R Dambaugh, E Kieff.   

Abstract

Epstein-Barr virus DNA is known to have partially homologous segments, designated DL and DR, near the left and right ends of the long unique region (Raab-Traub et al., Cell 22:257-267, 1980). DL and DR are each partially composed of tandem direct repeat sequences. DL contains 11 to 14 repeats of a 124-base-pair sequence designated IR2. DR contains approximately 30 direct repeats of a 103-base-pair sequence designated IR4. The DL and DR sequences have colinear partial homology for approximately 2.4 and 1.5 kilobase pairs to the right of IR2 and IR4, respectively. IR2 and IR4 are similar sequences and evolved in part from a common ancestor. Both sequences are 84% guanine and cytosine and have limited homology to Epstein-Barr virus IR1 and to the herpes simplex virus type 1 inverted terminal repeat "a" sequence. IR2 encodes part of an abundant 2.5-kilobase persistent early EBV RNA expressed in productively infected cells, but does not encode part of the 3-kilobase Epstein-Barr virus RNA which is transcribed from the adjacent IR1-U2 region of the Epstein-Barr virus genome in latently infected cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6294332      PMCID: PMC256339     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  The structure of the termini of the DNA of Epstein-Barr virus.

Authors:  C R Kintner; B Sugden
Journal:  Cell       Date:  1979-07       Impact factor: 41.582

2.  DNA of Epstein-Barr virus. III. Identification of restriction enzyme fragments that contain DNA sequences which differ among strains of Epstein-Barr virus.

Authors:  N Raab-Traub; R Pritchett; E Kieff
Journal:  J Virol       Date:  1978-08       Impact factor: 5.103

3.  DNA of Epstein-Barr virus. IV. Linkage map of restriction enzyme fragments of the B95-8 and W91 strains of Epstein-Barr Virus.

Authors:  D Given; E Kieff
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

4.  Evolution of repeated DNA sequences by unequal crossover.

Authors:  G P Smith
Journal:  Science       Date:  1976-02-13       Impact factor: 47.728

5.  pBR322 restriction map derived from the DNA sequence: accurate DNA size markers up to 4361 nucleotide pairs long.

Authors:  J G Sutcliffe
Journal:  Nucleic Acids Res       Date:  1978-08       Impact factor: 16.971

6.  A simple method for DNA restriction site mapping.

Authors:  H O Smith; M L Birnstiel
Journal:  Nucleic Acids Res       Date:  1976-09       Impact factor: 16.971

7.  The nucleotide sequence of bacteriophage phiX174.

Authors:  F Sanger; A R Coulson; T Friedmann; G M Air; B G Barrell; N L Brown; J C Fiddes; C A Hutchison; P M Slocombe; M Smith
Journal:  J Mol Biol       Date:  1978-10-25       Impact factor: 5.469

8.  Biological properties and viral surface antigens of Burkitt lymphoma- and mononucleosis- derived strains of Epstein-Barr virus released from transformed marmoset cells.

Authors:  G Miller; D Coope; J Niederman; J Pagano
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

9.  Alleles of the fibroin gene coding for proteins of different lengths.

Authors:  K U Sprague; M B Roth; R F Manning; L P Gage
Journal:  Cell       Date:  1979-06       Impact factor: 41.582

10.  Human cytomegalovirus genome: partial denaturation map and organization of genome sequences.

Authors:  B A Kilpatrick; E S Huang
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

View more
  24 in total

1.  Genetic diversity: frameshift mechanisms alter coding of a gene (Epstein-Barr virus LF3 gene) that contains multiple 102-base-pair direct sequence repeats.

Authors:  Shao-An Xue; M D Jones; Qi-Long Lu; J M Middeldorp; Beverly E Griffin
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

2.  Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.

Authors:  J I Cohen; F Wang; J Mannick; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

3.  A selectable marker allows investigation of a nontransforming Epstein-Barr virus mutant.

Authors:  A Marchini; J I Cohen; F Wang; E Kieff
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

4.  The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.

Authors:  J B Mannick; J I Cohen; M Birkenbach; A Marchini; E Kieff
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

5.  The Epstein-Barr virus (EBV) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z.

Authors:  H Gruffat; N Moreno; A Sergeant
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R.

Authors:  A Chevallier-Greco; H Gruffat; E Manet; A Calender; A Sergeant
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

7.  The Epstein-Barr virus (EBV) early promoter DR contains a cis-acting element responsive to the EBV transactivator EB1 and an enhancer with constitutive and inducible activities.

Authors:  P Chavrier; H Gruffat; A Chevallier-Greco; M Buisson; A Sergeant
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

8.  A second Epstein-Barr virus early antigen gene in BamHI fragment M encodes a 48- to 50-kilodalton nuclear protein.

Authors:  M S Cho; G Milman; S D Hayward
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

9.  Identification and characterization of an Epstein-Barr virus early antigen that is encoded by the NotI repeats.

Authors:  C M Nuebling; N Mueller-Lantzsch
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

10.  Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia.

Authors:  D M Walling; N Raab-Traub
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.